Patent · US Active

Somatostatin-dopamine chimeric analogs

US8822442B2 · kind B2 · utility

12Cited by

3References

28Claims

0Family size

Assignee

IPSEN PHARMA S.A.S. · FR

Inventors

Zheng Xin Dong · Holliston, US
Michael DeWitt Culler · Gretna, US
Yeelena Shen · Franklin, US

Key dates

Filing date	Oct 28, 2005
Grant date	Sep 2, 2014
Priority date	—
Expiry date	Mar 13, 2029

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features somatostatin-dopamine chimeric analogs and methods relating to their therapeutic use for the treatment of neoplasia, acromegaly, and other conditions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.